Meo Muhammad Os, Meo Muhammad Zs, Khan Isra M, Butt Muhammad As, Usmani Adnan M, Meo Sultan A
From the College of Medicine (MOS Meo, MZS Meo, Khan), Alfaisal University; from the Department of Family Medicine (Butt) and Department of Physiology (S. Meo), College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Saudi Med J. 2024 Dec;45(12):1334-1339. doi: 10.15537/smj.2024.45.12.20240720.
To explore the global epidemiological trends in the prevalence and mortality due to mpox in various regions worldwide.
In this cross-sectional study the data about mpox outbreak were recorded by the "World Health Organization, Centers for Disease Control and Prevention, and GSAID" from August 2023 to August 2024, analyzing the epidemiological trends from different countries worldwide.
The total number of mpox cases has reached 99,518 (95,196 cases from 115 countries that have not historically reported mpox; and 4,322 cases from 07 states that have traditionally reported mpox), from a total of 122 countries. The top 10 countries with the greatest number of mpox cases include the United States (33,435) followed by Brazil (11212), Spain (8084), France (4272), Colombia (4249), Mexico (4124), United Kingdom (3952), Peru (3875), Germany (3857), and Democratic Republic of Congo (3104). America has the highest number of cases (63,145) accounting for 63% of total cases globally, followed by Europe (27,194). Democratic Republic of Congo faces the highest increase in cases within a single year, with the infectious rate in the region up by 160%, alongside a higher risk of mortality.
Mpox cases have rapidly spread worldwide, reaching 99,518 cases across 122 countries, and being declared a "Public Health Emergency of International Concern" by the WHO. Healthcare authorities must take timely measures to control this outbreak since the world cannot afford the global burden of it being another potential pandemic.
探讨全球各地区猴痘流行率和死亡率的全球流行病学趋势。
在这项横断面研究中，世界卫生组织、疾病控制与预防中心以及全球共享流感数据倡议组织（GISAID）记录了2023年8月至2024年8月期间猴痘疫情的数据，分析了全球不同国家的流行病学趋势。
来自122个国家的猴痘病例总数已达99518例（其中来自115个历史上未报告过猴痘的国家的病例有95196例；来自7个传统上报告过猴痘的州的病例有4322例）。猴痘病例数最多的前10个国家包括美国（33435例），其次是巴西（11212例）、西班牙（8084例）、法国（4272例）、哥伦比亚（4249例）、墨西哥（4124例）、英国（3952例）、秘鲁（3875例）、德国（3857例）和刚果民主共和国（3104例）。美洲的病例数最多（63145例），占全球病例总数的63%，其次是欧洲（27194例）。刚果民主共和国一年内病例数增长幅度最大，该地区的感染率上升了160%，同时死亡风险也更高。
猴痘病例已在全球迅速传播，122个国家的病例数达99518例，世界卫生组织已将其宣布为“国际关注的突发公共卫生事件”。鉴于全球难以承受其成为另一场潜在大流行所带来的负担，卫生保健当局必须及时采取措施控制此次疫情。
